Annual EBIT
-$4.52 M
+$2.20 M+32.78%
01 December 2023
Summary:
Xenetic Biosciences annual earnings before interest & taxes is currently -$4.52 million, with the most recent change of +$2.20 million (+32.78%) on 01 December 2023. During the last 3 years, it has risen by +$178.80 thousand (+3.81%). XBIO annual EBIT is now -5826.12% below its all-time high of -$37.70 thousand.XBIO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$499.50 K
+$837.90 K+62.65%
01 September 2024
Summary:
Xenetic Biosciences quarterly earnings before interest & taxes is currently -$499.50 thousand, with the most recent change of +$837.90 thousand (+62.65%) on 01 September 2024. Over the past year, it has increased by +$647.20 thousand (+56.44%). XBIO quarterly EBIT is now -111.27% below its all-time high of $4.43 million, reached on 31 December 2017.XBIO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$4.36 M
+$647.20 K+12.92%
01 September 2024
Summary:
Xenetic Biosciences TTM earnings before interest & taxes is currently -$4.36 million, with the most recent change of +$647.20 thousand (+12.92%) on 01 September 2024. Over the past year, it has increased by +$462.40 thousand (+9.59%). XBIO TTM EBIT is now -29366.22% below its all-time high of -$14.80 thousand, reached on 30 November 2011.XBIO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XBIO EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +32.8% | +56.4% | +9.6% |
| 3 y3 years | +3.8% | +63.7% | +14.4% |
| 5 y5 years | +37.9% | +91.2% | +56.4% |
XBIO EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +32.8% | at high | +81.4% | at high | +42.3% |
| 5 y | 5 years | at high | +53.0% | at high | +91.2% | at high | +56.4% |
| alltime | all time | -5826.1% | +91.6% | -111.3% | +99.0% | <-9999.0% | +92.7% |
Xenetic Biosciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$499.50 K(-62.7%) | -$4.36 M(-12.9%) |
| June 2024 | - | -$1.34 M(+5.4%) | -$5.01 M(+2.9%) |
| Mar 2024 | - | -$1.27 M(+1.0%) | -$4.87 M(+7.8%) |
| Dec 2023 | -$4.52 M(-32.8%) | -$1.26 M(+9.5%) | -$4.52 M(-6.4%) |
| Sept 2023 | - | -$1.15 M(-4.3%) | -$4.82 M(+6.6%) |
| June 2023 | - | -$1.20 M(+30.9%) | -$4.52 M(-24.8%) |
| Mar 2023 | - | -$915.20 K(-41.5%) | -$6.01 M(-10.5%) |
| Dec 2022 | -$6.72 M(+16.9%) | -$1.56 M(+84.4%) | -$6.72 M(-4.4%) |
| Sept 2022 | - | -$847.80 K(-68.4%) | -$7.03 M(-7.0%) |
| June 2022 | - | -$2.69 M(+65.9%) | -$7.56 M(+26.0%) |
| Mar 2022 | - | -$1.62 M(-13.6%) | -$6.00 M(+4.4%) |
| Dec 2021 | -$5.75 M(+22.4%) | -$1.87 M(+36.2%) | -$5.75 M(+12.8%) |
| Sept 2021 | - | -$1.38 M(+22.0%) | -$5.09 M(+2.3%) |
| June 2021 | - | -$1.13 M(-17.6%) | -$4.98 M(+3.0%) |
| Mar 2021 | - | -$1.37 M(+12.2%) | -$4.83 M(+2.9%) |
| Dec 2020 | -$4.69 M(-51.1%) | -$1.22 M(-3.3%) | -$4.69 M(-0.3%) |
| Sept 2020 | - | -$1.26 M(+28.4%) | -$4.71 M(-48.3%) |
| June 2020 | - | -$982.50 K(-20.2%) | -$9.11 M(-4.2%) |
| Mar 2020 | - | -$1.23 M(-0.3%) | -$9.51 M(-1.0%) |
| Dec 2019 | -$9.60 M(+32.0%) | -$1.23 M(-78.2%) | -$9.60 M(-4.0%) |
| Sept 2019 | - | -$5.66 M(+310.9%) | -$10.01 M(+62.5%) |
| June 2019 | - | -$1.38 M(+3.9%) | -$6.16 M(-9.1%) |
| Mar 2019 | - | -$1.33 M(-19.0%) | -$6.78 M(-6.9%) |
| Dec 2018 | -$7.28 M(+103.9%) | -$1.64 M(-9.7%) | -$7.28 M(+503.3%) |
| Sept 2018 | - | -$1.81 M(-9.0%) | -$1.21 M(-26.1%) |
| June 2018 | - | -$1.99 M(+9.0%) | -$1.63 M(-35.8%) |
| Mar 2018 | - | -$1.83 M(-141.3%) | -$2.54 M(-28.8%) |
| Dec 2017 | -$3.57 M | $4.43 M(-297.8%) | -$3.57 M(-57.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$2.24 M(-22.8%) | -$8.35 M(+1.3%) |
| June 2017 | - | -$2.90 M(+1.7%) | -$8.24 M(-84.5%) |
| Mar 2017 | - | -$2.86 M(+711.5%) | -$53.01 M(-0.9%) |
| Dec 2016 | -$53.48 M(+336.9%) | -$351.90 K(-83.5%) | -$53.48 M(-5.5%) |
| Sept 2016 | - | -$2.13 M(-95.5%) | -$56.62 M(-5.1%) |
| June 2016 | - | -$47.67 M(+1333.1%) | -$59.68 M(+354.3%) |
| Mar 2016 | - | -$3.33 M(-4.7%) | -$13.14 M(+7.3%) |
| Dec 2015 | -$12.24 M(-14.4%) | -$3.49 M(-32.8%) | -$12.24 M(-6.2%) |
| Sept 2015 | - | -$5.20 M(+362.3%) | -$13.05 M(+18.3%) |
| June 2015 | - | -$1.12 M(-53.8%) | -$11.04 M(-12.9%) |
| Mar 2015 | - | -$2.43 M(-43.5%) | -$12.67 M(-11.4%) |
| Dec 2014 | -$14.30 M(+66.7%) | -$4.30 M(+35.2%) | -$14.30 M(+41.9%) |
| Sept 2014 | - | -$3.18 M(+15.4%) | -$10.08 M(+44.6%) |
| June 2014 | - | -$2.76 M(-32.1%) | -$6.97 M(+65.1%) |
| Mar 2014 | - | -$4.06 M(+5189.2%) | -$4.22 M(+2877.5%) |
| Dec 2013 | -$8.58 M(>+9900.0%) | - | - |
| Nov 2013 | - | -$76.80 K(+5.3%) | -$141.80 K(+85.8%) |
| Aug 2013 | - | -$72.90 K(+607.8%) | -$76.30 K(+75.4%) |
| Aug 2013 | -$76.20 K(-98.8%) | - | - |
| May 2013 | - | -$10.30 K(-156.6%) | -$43.50 K(-36.8%) |
| Feb 2013 | - | $18.20 K(-261.1%) | -$68.80 K(-39.2%) |
| Dec 2012 | -$6.28 M(+5278.4%) | - | - |
| Nov 2012 | - | -$11.30 K(-71.8%) | -$113.10 K(-3.0%) |
| Aug 2012 | - | -$40.10 K(+12.6%) | -$116.60 K(+52.4%) |
| Aug 2012 | -$116.70 K | - | - |
| May 2012 | - | -$35.60 K(+36.4%) | -$76.50 K(+87.0%) |
| Feb 2012 | - | -$26.10 K(+76.4%) | -$40.90 K(+176.4%) |
| Nov 2011 | - | -$14.80 K | -$14.80 K |
FAQ
- What is Xenetic Biosciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Xenetic Biosciences?
- What is Xenetic Biosciences annual EBIT year-on-year change?
- What is Xenetic Biosciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Xenetic Biosciences?
- What is Xenetic Biosciences quarterly EBIT year-on-year change?
- What is Xenetic Biosciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Xenetic Biosciences?
- What is Xenetic Biosciences TTM EBIT year-on-year change?
What is Xenetic Biosciences annual earnings before interest & taxes?
The current annual EBIT of XBIO is -$4.52 M
What is the all time high annual EBIT for Xenetic Biosciences?
Xenetic Biosciences all-time high annual earnings before interest & taxes is -$37.70 K
What is Xenetic Biosciences annual EBIT year-on-year change?
Over the past year, XBIO annual earnings before interest & taxes has changed by +$2.20 M (+32.78%)
What is Xenetic Biosciences quarterly earnings before interest & taxes?
The current quarterly EBIT of XBIO is -$499.50 K
What is the all time high quarterly EBIT for Xenetic Biosciences?
Xenetic Biosciences all-time high quarterly earnings before interest & taxes is $4.43 M
What is Xenetic Biosciences quarterly EBIT year-on-year change?
Over the past year, XBIO quarterly earnings before interest & taxes has changed by +$647.20 K (+56.44%)
What is Xenetic Biosciences TTM earnings before interest & taxes?
The current TTM EBIT of XBIO is -$4.36 M
What is the all time high TTM EBIT for Xenetic Biosciences?
Xenetic Biosciences all-time high TTM earnings before interest & taxes is -$14.80 K
What is Xenetic Biosciences TTM EBIT year-on-year change?
Over the past year, XBIO TTM earnings before interest & taxes has changed by +$462.40 K (+9.59%)